GlaxoSmithKline's consumer health business will be named ... The name of the unit – whose brands include Sensodyne toothpaste and Voltaren and Panadol painkillers and Centrum multivitamins ...

GSK has begun the sale of some of its consumer health brands, hoping to raise around £1 billion before spinning off its consumer healthcare business, according to reports.

With Pfizer’s final stake sale in the bag, the two Big Pharma companies behind Haleon’s genesis have formally parted ways with the standalone consumer health giant. | After charting similar moves ...

Bengaluru: Pfizer will divest its remaining stake in Haleon, marking its complete exit from the British consumer healthcare ...

We think GSK's decision to divest the consumer business is likely to unlock value over the long run. GSK divested Haleon, its consumer group, in July 2022. Given the strong valuations of consumer ...

Twelve months on from the first lockdowns in the west, brands and media are taking stock of the past year and making decisions on where to go next. Looking back, Tamara Rogers, global CMO at GSK ...

The rebrand comes after GSK transferred its consumer health business to Haleon to focus on innovative drugs. Haleon will now encompass consumer health brands including Sensodyne, Panadol, Eno, and ...

At Tata Consumer Products, Das drives growth strategy, outcomes and profit & loss for the packaged beverages category in ...

GSK has rejected three bids from Unilever for its consumer arm, which is home to brands such as Sensodyne toothpaste, Emergen-C vitamin supplement and Panadol painkiller, saying the bids ...